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While most school districts utilize a drug abuse resis-
tance curriculum, as science teachers, it is our respon-
sibility to understand the science behind drug addic-
tion in order to most effectively educate our students 
against drug abuse. In the last two decades, increases 
in scientific technology have permitted significant dis-
coveries surrounding the neurobiology, genetic com-
ponents, and treatment of drug addiction. This article 
addresses the latest scientific knowledge about drug 
addiction and treatment with information that can be 
used in the middle school setting, focusing on cocaine 
addiction to illustrate the points discussed. 
What is drug addiction?
Most scientists now consider drug addiction a biomedi-
cal rather than a psychological condition, or a failure 
of will, as many laypersons still believe. The American 
Medical Association, American Psychiatric Association, 
and other organizations now describe drug addiction 
as a brain disease that causes an uncontrollable, com-
pulsive drug craving, seeking, and use even in the face 
of negative health and social consequences. Addiction 
must be distinguished from the term dependence, which 
refers to whether physical or psychological withdrawal 
symptoms will occur if drug use is discontinued. Cer-
tain drugs, such as heroin and alcohol, create physical 
dependence, while other drugs, such as cocaine, pro-
duce very few symptoms of physical dependence and 
are therefore referred to as primarily creating psycho-
logical dependence.
 Drug education programs of the past, particularly 
in the 1970s and 1980s, highlighted physical versus 
psychological addiction, an emphasis that is now seen 
as archaic in the drug treatment world. Addiction can 
occur whether the drug used creates physical or psy-
chological dependence, and the compulsion to use the 
two classes of drugs can be equal. Addiction causes 
physical changes in the brain, regardless of whether 
the drug used causes physical withdrawal symptoms 
upon discontinuance, and it is these changes in brain 
function that result in the addict’s compulsion to con-
tinue drug use.
 An analogy used to illustrate how addiction occurs 
is that “after a certain amount of a drug is consumed, 
it is as if a switch in the brain is flipped from normal 
to addict” (Leshner 2001). The amount of drugs that 
must be consumed to cause these brain changes is dif-
ferent for everyone, which helps to explain why some 
people become addicted after low to moderate drug use 
when others can use higher levels of drugs or use them 
for longer periods of time and not show symptoms of 
addiction (Leshner 2001). Specifically, in the case of 
cocaine and related stimulant drugs (such as crystal 
methamphetamine), some addicts report that craving 
began after as few as one to two incidents of use.
 Recent scientific evidence suggests that between 
50–70% of the variability in susceptibility to becoming 
addicted is due to genetic factors, while environmental 
and biological factors also play a role (Leshner 2001). 
Therefore, while it is accurate to state that addiction 
can run in families due to their shared genetic makeup, 
an absence of addicts in a family does not remove the 
possibility of genetic predisposition to addiction. This 
is why the phrase “be smart, don’t start” represents 
the most effective way to prevent addiction. Abstaining 
entirely from drug use will prevent addiction from oc-
curring, regardless of whether or not a genetic predis-
position to addiction is present.
 For those who do not heed this advice and become 
addicted, even if their brain function is returned to 
normal after treatment, it is possible that the psycho-
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logical effects of addiction, including the compulsion 
to use drugs, can continue for years after drug use has 
stopped. Stressing these points—that one cannot pre-
dict when addiction will develop, that one can carry a 
genetic predisposition to addiction without knowing it, 
that addiction can develop even after only low levels of 
drug use, and that the effects of addiction can last long 
after treatment—when educating students strengthens 
the argument that prevention and abstinence from all 
drug use are the most effective treatment.
 While it is true that a drug user initially voluntarily 
chooses to engage in drug use, the neurobiology re-
search contradicts the notion that the user can sim-
ply “decide” to quit. Due to the changes in the brain 
over time, the addict loses control over what was 
once voluntary drug use, and that behavior becomes 
compulsive and truly uncontrollable, much like other 
behavioral expressions of brain disease. For example, 
Parkinson’s patients cannot control their trembling, 
nor can schizophrenics control their hallucinations. 
It is important for students to understand that due to 
changes in the brain, outside help and medical treat-
ment are almost always necessary to break addiction. 
While stories of individuals who are able to break their 
addiction without outside help are indeed true, it is 
estimated that less than 1 in 10 former addicts success-
fully quits without formal treatment. When compared 
to the total number of current and former addicts and 
those who have died from drug use, it becomes readily 
apparent how few drug addicts recover without formal 
treatment. Understanding the extreme difficulty in 
quitting without formal treatment helps students to 
understand why family members are so often unsuc-
cessful in changing the behavior of their loved ones 
who struggle with addiction, no matter how hard they 
try or how much they are loved by the addict. 
What causes the high?
The sense of a drug “high” comes from the effect of the 
drug on the process of neurotransmission in the brain. 
Most science teachers are familiar with information in 
the brain being delivered from one neuron to another 
in a nerve pathway using chemicals called neurotrans-
mitters. The neurotransmitters carry the signal from 
the sending neuron to the receiving neuron across the 
synapse, the space between neurons. Common neu-
rotransmitters in the brain include dopamine, serotonin, 
gamma-aminobutyric acid (GABA), and acetylcholine. 
Dopamine, the specific neurotransmitter affected by 
cocaine use, is directly or indirectly affected by virtu-
ally every addictive substance. Dopamine is released in 
two ways: (1) in constant, low levels (called tonic levels) 
that aid in proper brain and motor function, and (2) in 
higher levels during a person’s engagement in activities 
that activate the reward pathway of the brain, such as 
eating, sex, or addictive drug use.
 Drugs of abuse alter normal neurotransmission by 
increasing the level or effect of the neurotransmitter 
in the brain. This can be accomplished by increasing 
the production or release of neurotransmitters, by en-
hancing the reception of the neurotransmitter at the 
receiving neuron, or by preventing neurotransmitter 
reuptake in/return to the sending neuron from which it 
was released. No matter the exact mechanism, the drug 
high is a result of increasing the neurotransmitter’s ef-
fect, causing an increased stimulus of the receiving 
neurons. This state of overstimulation of the receiving 
neurons by the neurotransmitters (specifically, dop-
amine) causes the feelings of euphoria and satisfaction 
reported by drug users.
 When dopamine is released by the sending neuron 
to the receiving one, it binds to dopamine receptors on 
the receiving neuron’s surface. After the signal is sent, 
dopamine is transported back to the sending neuron by 
a specialized protein, the dopamine transporter. Cocaine 
increases dopamine levels by binding to the dopamine 
transporters, thus preventing dopamine’s reuptake by 
the sending neurons and thereby causing a buildup of 
dopamine in the synapse. This buildup floods the dop-
amine receptors on the receiving neuron. It is this ex-
cess of dopamine in the synapse that causes excessive 
stimulation of the receiving neurons and the euphoria 
associated with cocaine use.
What treatments are possible?
Historically, psychosocial intervention (counseling) has 
been used to help addicts fight their drug addictions. 
Examples include the counseling groups sponsored 
by organizations such as Alcoholics Anonymous and 
Narcotics Anonymous, as well as more individualized 
inpatient and outpatient counseling programs.
 Medical intervention for drug addiction is often com-
bined with psychosocial intervention. All the current 
medical therapies work by either causing severe nega-
tive side effects if the drug of abuse is used, or by sub-
stituting a drug that acts on the same receptors as the 
drug of abuse and therefore allows the drug addict to 
engage more effectively in psychosocial therapy with-
out constant craving and compulsion to use drugs. For 
example, Antabuse is a drug commonly prescribed to 
alcohol-dependent patients; nausea and vomiting occur 
if alcohol is consumed while taking Antabuse. The nico-
tine patch, which is actually a source of nicotine and 
not another type of drug, acts exactly the same way as 
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tobacco on nicotine receptors. The idea behind its use 
is that the patch satisfies the addict’s nicotine craving 
while removing the psychological and social cues that 
reinforce smoking behavior, and decreases the nicotine 
dosage over time while permitting addicts to engage in 
psychosocial therapy and ultimately wean themselves 
from the need for nicotine. Unlike the nicotine patch, 
methadone, which is used in heroin addiction therapy, 
is an example of a drug that is similar to the drug of 
abuse but is not the same chemical compound. A prob-
lem with nearly all treatments that substitute another 
drug for the drug of abuse is that the substitute itself 
has an approximately equivalent addictive liability if 
misused; meaning, it is possible to become addicted to 
the treatment.
 Cocaine addiction, until recently, has shown to be 
highly resistant to medical treatment. The mechanism 
of cocaine addiction via its effect on dopamine levels has 
been known for over a decade, but medical treatments 
aimed at affecting the dopamine receptors have gener-
ally been unsuccessful due to the fact that the dopamine 
pathway is intricately linked to mood, motor control, and 
proper mental functioning (recall the examples of Parkin-
son’s disease and schizophrenia mentioned above, which 
result from malfunctions of the dopamine neurotransmit-
ter systems). Blocking the reception of dopamine means 
that not only is the reward-pathway release of dopamine 
blocked as a result of drug use, but the normal (tonic) 
level of dopamine the body needs to function properly 
also cannot be maintained. Therefore, drug addiction 
therapies that block the dopamine receptors have often 
been either unsuccessful at halting addiction or have 
caused undesirable side effects in patients.
 Experimental therapies aimed instead at preventing 
the release of dopamine during excitation of the reward 
pathway are providing promise in treating cocaine addic-
tion. Some of these therapies have capitalized on using 
the neurotransmitter GABA, which inhibits dopamine’s 
release. GABA regulates the overall excitability of the 
human brain. If dopamine can be considered the gas 
pedal of a car, GABA is the brake (Lemonick 2007). 
When GABA is released, it blocks dopamine release via 
the reward pathway, while still allowing for tonic release, 
and thereby keeps the neurons in a normal, balanced 
state. The reasoning for this GABA-based approach to 
drug addiction therapy is that if reward-activated dop-
amine release can be inhibited, the excessive levels of 
dopamine flooding the synapses will be avoided, thus 
eliminating the high experienced during cocaine use, but 
normal tonic functioning will still be preserved. 
 Examples of GABA-active drugs include tranquilizers 
and antiseizure medications. Among the most promis-
ing of these in fighting cocaine addiction is vigabatrin 
(gamma-vinyl GABA), which is currently being tested 
across the United States at multiple treatment centers 
(ClinicalTrials.gov 2008). Vigabatrin is a drug used out-
side of the United States to treat epilepsy. It is unique 
among the GABA-active drugs because it prevents the 
breakdown of GABA; therefore, when a neuron receives 
the signal to release GABA there is a vast storehouse of 
GABA available, far more than would normally be pres-
ent. The end result of this increased amount of available 
GABA is that reward-pathway-dopamine release is highly 
inhibited, which prevents the usual craving for cocaine 
and the high and feelings of euphoria even if cocaine is 
still used. In essence, vigabatrin combats the excitability 
of the neurons normally affected by cocaine and keeps 
the addict’s craving and psychological compulsion to use 
cocaine in check, even if the addict falls off the wagon, en-
gaging in drug use during psychosocial treatment. This 
is highly important for addicts who do not check into a 
residential treatment center and instead opt to engage in 
outpatient therapy, where the same external stimuli and 
outside stresses and pressures to use cocaine are pres-
ent. Vigabatrin should not be viewed as a cure for cocaine 
addiction; its goal is to decrease or remove the craving 
and high associated with cocaine in order to make psy-
chological treatment of addiction more effective.
 Interestingly, recent research has shown that virtually 
all addictive substances activate this dopamine neuro-
chemical pathway, and it is this neurochemical pathway 
that is responsible for sending the “that feels good” sig-
nal when an addictive substance is consumed. Dr. Frank 
Vocci, director of pharmacotherapies at the National 
Institute of Drug Abuse, was quoted in Time magazine 
regarding vigabatrin, saying optimistically, “If it works, it 
will probably work on all addictions” (Lemonick 2007). It 
is expected that results from the clinical trials on vigaba-
trin will be available in 2009, along with an examination 
of any side effects and potential dangers of treatment.
Final words
When discussing drugs and addiction with students, 
there are two primary purposes: (1) preventing use, 
abuse, and thereby possible addiction in students, now 
or in the future, and (2) helping students to understand 
addiction so that they can understand the behavior of 
others and know the options for treatment. There are 
still many people—youth and adults—who believe not 
only that addiction is purely psychological and can be 
halted at will, but also that because addiction begins with 
a voluntary act, it does not deserve to be classified as a 
disease. Thus, discussions of addiction can be emotional 
and heated, and as teachers we need to be prepared with 
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scientific evidence to support any claim we might make 
or concept we might teach. While it is true addiction 
starts with a voluntary act, the complex neurochemical 
cascade that follows this voluntary act is what makes ad-
diction a disease rather than a conscious choice.  
 While focusing on drug avoidance and decision-mak-
ing strategies is highly important in aiding students 
to abstain from drug use, early adolescents in middle 
grades are more able than their younger counterparts 
to grasp the scientific mechanisms of drug action and 
to understand the genetic predisposition that some indi-
viduals have to addiction. If we employ a total approach 
to drug education in our curricula, incorporating up-to-
date information on the psychological, scientific, and 
social underpinnings of drug use and addiction, we can 
aspire to be even more effective than we have been in 
the past at helping our students live healthy lives. 
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